|
|
Volumn 163, Issue 4, 2013, Pages 1214-1216
|
|
A single histrelin implant is effective for 2 years for treatment of central precocious puberty
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTRADIOL;
HISTRELIN;
LUTEINIZING HORMONE;
TESTOSTERONE;
BODY MASS;
BONE AGE;
BONE MATURATION;
BREAST AUGMENTATION;
CHILD;
CLINICAL ARTICLE;
CONFERENCE PAPER;
ESTRADIOL BLOOD LEVEL;
FEMALE;
GROWTH ACCELERATION;
HUMAN;
LUTEINIZING HORMONE BLOOD LEVEL;
MALE;
PRECOCIOUS PUBERTY;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
SCHOOL CHILD;
TESTOSTERONE BLOOD LEVEL;
WEIGHT GAIN;
CENTRAL PRECOCIOUS PUBERTY;
CPP;
GNRHA;
GONADOTROPIN RELEASING HORMONE ANALOG;
HPG;
HYPOTHALAMIC-PITUITARY-GONADAL;
LH;
LUTEINIZING HORMONE;
ULTRASENSITIVE;
US;
CHILD;
CHILD, PRESCHOOL;
DRUG IMPLANTS;
FEMALE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
HYPOTHALAMO-HYPOPHYSEAL SYSTEM;
LUTEINIZING HORMONE;
MALE;
PUBERTY, PRECOCIOUS;
SEX FACTORS;
TIME FACTORS;
|
|
EID: 84884671141
PISSN: 00223476
EISSN: 10976833
Source Type: Journal
DOI: 10.1016/j.jpeds.2013.05.033 Document Type: Conference Paper |
|
Times cited : (61)
|
|
References (7)
|
